S&P revises Anne Arundel Health System’s rating to ‘A’

Standard & Poor’s has raised its long-term rating on Annapolis, Md.-based Anne Arundel Health System’s bonds to “A” from “A-“.

Advertisement

S&P also affirmed the “AAA/A-1” rating on AAHS’ series 2009B bonds based on the application of its joint criteria.

The rating revision is based on several factors, including AAHS’ excellent market share presence and strong financial profile.

The outlook for all ratings is stable, reflecting S&P’s belief that AAHS will successfully manage its global revenue budget agreement while maintaining its business position.

More articles on finance:
Moody’s changes outlook to negative on UPMC’s bonds
Moody’s downgrades Sonoma Valley Health District’s GO bonds to ‘Baa1’
For-profit hospital stock report: Week of Sept. 21-25

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.